According to Medistim's latest financial reports the company's current EPS (TTM) is โน47.96. In 2023 the company made an earnings per share (EPS) of โน48.14 a decrease over its 2022 EPS that were of โน55.11.
Year | EPS | Change |
---|---|---|
2024 (TTM) | โน46.44 | -3.53% |
2023 | โน48.14 | -12.65% |
2022 | โน55.11 | 12.85% |
2021 | โน48.83 | 26.94% |
2020 | โน38.47 | 1.75% |
2019 | โน37.81 | 21.73% |
2018 | โน31.06 | 12.93% |
2017 | โน27.50 | 28.21% |
2016 | โน21.45 | -1.91% |
2015 | โน21.87 | 8.85% |
2014 | โน20.09 | -3.68% |
2013 | โน20.86 | -18.65% |
2012 | โน25.64 | 109.16% |
2011 | โน12.26 | -18.07% |
2010 | โน14.96 | -33.5% |
2009 | โน22.50 | 139.28% |
2008 | โน9.40 | -60.7% |
2007 | โน23.93 | 81.99% |
2006 | โน13.15 | 63.49% |
2005 | โน8.04 | 20.58% |
2004 | โน6.67 |